Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The America Watch.
Press releases published on April 25, 2025
Guckenheimer Tops National Food Service Industry Protein Sustainability Scorecard for Fourth Consecutive Year
GlobeNewswire
·
April 25, 2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Guckenheimer, the food service arm of global workplace experience and facility management leader ISS, has once again earned the #1 ranking on the Humane World for Animals’ (formerly The Humane Society of the …
SalesHood Promotes Josh Cruickshank Chief Customer Officer to Drive Global Customer Success and Deliver Business Impact For Our Customers
GlobeNewswire
·
April 25, 2025
San Francisco, April 25, 2025 (GLOBE NEWSWIRE) -- SalesHood, the leading sales enablement platform, is proud to announce the promotion of Josh Cruickshank to Chief Customer Officer. In his new role, Josh will lead the company’s global customer success and …
ALX Oncology Reports ASPEN-03 and ASPEN-04 Phase 2 Trials Evaluating Evorpacept with a Checkpoint Inhibitor for the Treatment of Head and Neck Cancers Did Not Meet Primary Endpoints
GlobeNewswire
·
April 25, 2025
In ASPEN-03 and ASPEN-04 trials, efficacy data do not support advancing evorpacept in combination with Merck’s anti-PD-1 therapy, KEYTRUDA® (pembrolizumab), into a registrational study Company remains confident in continuing to pursue evorpacept in …
Mangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pouch Division
GlobeNewswire
·
April 25, 2025
DALLAS, TX, April 25, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals Inc. (NASDAQ: MGRX) (“Mangoceuticals” or “MGRX”), a company focused on developing, marketing, and selling a variety of health and wellness products via a secure telemedicine platform under the …
Grayscale Investments Appoints Ramona Boston as Chief Marketing Officer
GlobeNewswire
·
April 25, 2025
New strategic hire bolsters firm’s growth with financial services expertise Boston will join shortly after arrival of incoming COO Diana Zhang STAMFORD, Conn., April 25, 2025 (GLOBE NEWSWIRE) -- Grayscale Investments, the world’s largest crypto-native …
As the price of Bitcoin (BTC) continues to rise recently, many Bitcoin (BTC) players have started to start Dogecoin (DOGE) in blockchain cloud mining to earn more lucrative returns
GlobeNewswire
·
April 25, 2025
Dublin, California, April 25, 2025 (GLOBE NEWSWIRE) -- It is worth mentioning that Burak Kesmeci, a well-known cryptocurrency analyst, shared an interesting on-chain analysis of the Bitcoin (BTC) market in a new article on the X platform. The analyst …
Hawkins, Inc. Expands Water Treatment Offerings with Complementary Acquisition of WaterSurplus
GlobeNewswire
·
April 25, 2025
ROSEVILLE, Minn., April 25, 2025 (GLOBE NEWSWIRE) -- Hawkins, Inc. (Nasdaq: HWKN), a leading water treatment and specialty ingredients company, has completed the acquisition of the assets of Surplus Management, Inc., doing business as WaterSurplus. …
Notice of Settlement of Shareholder Derivative Actions
GlobeNewswire
·
April 25, 2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Peloton Interactive, Inc. (NASDAQ: PTON) today released the following pursuant to an Order of the U.S. District Court for the Eastern District of New York. UNITED STATES DISTRICT COURT EASTERN DISTRICT OF NEW …
The Ebony Canal, Narrated by Viola Davis Wins Big with Two International Webby Awards for Black Infant and Maternal Health
GlobeNewswire
·
April 25, 2025
New York, New York, April 25, 2025 (GLOBE NEWSWIRE) -- Less than a week following National Black Maternal Health Week, The Ebony Canal, directed by four-time Emmy Award-winner Emmai Alaquiva and narrated by EGOT winner Viola Davis, has been honored with …
Better Choice Company Cancels Previously Announced Stock Dividend
GlobeNewswire
·
April 25, 2025
TAMPA, Fla., April 25, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, today announced that it is canceling the previously declared stock dividend of 0.35 per …
Better Choice Company Announces Closing of the SRx Health Merger, Name/Symbol Change and Completes $8.8 Million Private Placement Priced Above Last Market Closing Price
GlobeNewswire
·
April 25, 2025
TAMPA, Fla., April 25, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, today announced the closing of its business combination with SRx Health Solutions, Inc. …
OTCQX Best 50 Virtual Investor Conference: Presentations Now Available for Online Viewing
GlobeNewswire
·
April 25, 2025
NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the OTCQX Best 50 Virtual Investor Conference, held April 24th are now available for …
Coeptis Therapeutics, Inc. and Z Squared Inc. Announce Merger Agreement
GlobeNewswire
·
April 25, 2025
WEXFORD, Pa., April 25, 2025 (GLOBE NEWSWIRE) -- Coeptis Therapeutics Holdings, Inc. (Nasdaq; COEP) (“Coeptis” or the “Company”), a biopharmaceutical and technology company focused on developing innovative cell therapy platforms for cancer, autoimmune and …
Reducto Raises $24.5M Series A Round to Help Enterprises Unlock Unstructured Data
GlobeNewswire
·
April 25, 2025
SAN FRANCISCO, April 25, 2025 (GLOBE NEWSWIRE) -- Reducto, the most accurate ingestion platform for unlocking unstructured data for AI pipelines, announced today that it has raised a $24.5M series A round of funding led by Benchmark, alongside existing …
Pacific Financial Corp Earns $2.4 Million, or $0.24 per Diluted Share for First Quarter 2025; Board of Directors Approves 5% Stock Buyback Plan; Declares Quarterly Cash Dividend of $0.14 per Share
GlobeNewswire
·
April 25, 2025
ABERDEEN, Wash., April 25, 2025 (GLOBE NEWSWIRE) -- Pacific Financial Corporation (OTCQX: PFLC), (“Pacific Financial”) or the (“Company”), the holding company for Bank of the Pacific (the “Bank”), reported net income of $2.4 million, or $0.24 per diluted …
Preferred Bank Reports First Quarter Results
GlobeNewswire
·
April 25, 2025
LOS ANGELES, April 25, 2025 (GLOBE NEWSWIRE) -- Preferred Bank (NASDAQ: PFBC), one of the larger independent California banks, today reported results for the quarter ended March 31, 2025. Preferred Bank (“the Bank”) reported net income of $30.0 million or …
Syncromune® Inc. to Present Clinical Data from SYNC-T Therapy SV-102 Phase 1 Trial at the American Society for Clinical Oncology Annual Meeting 2025
GlobeNewswire
·
April 25, 2025
FORT LAUDERDALE, Fla. and WEST DES MOINES, Iowa, April 25, 2025 (GLOBE NEWSWIRE) -- Syncromune®, Inc., a clinical-stage biopharmaceutical company dedicated to the development of SYNC-T, an in situ platform combination therapy optimized for solid tumor …
Telos Corporation to Announce First Quarter 2025 Financial Results on May 9, 2025
GlobeNewswire
·
April 25, 2025
ASHBURN, Va., April 25, 2025 (GLOBE NEWSWIRE) -- Telos Corporation (NASDAQ: TLS), a leading provider of cyber, cloud and enterprise security solutions for the world’s most security-conscious organizations, today announced that it will report first quarter …
Porsche celebrates fifty years since the original audacious adventure
GlobeNewswire
·
April 25, 2025
Atlanta., April 25, 2025 (GLOBE NEWSWIRE) -- On April 28, 1975 a one-off Porsche 917 race car left the Weissach development center. It headed not for a track – like every 917 before – but instead, and for the very first time, it took to public roads. It …
CERo Therapeutics Holdings, Inc. to Present Poster on Lead Program, CER-1236, at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting
GlobeNewswire
·
April 25, 2025
SOUTH SAN FRANCISCO, Calif, April 25, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) (“CERo” or the “Company”) an innovative immunotherapy company seeking to advance the next generation of engineered T cell therapeutics that …